Home
/
Medpace Holdings, Inc.
/
Financials
/
Quarterly
Medpace Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Medpace Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$163.08M
May 1, 2018
Q1
2018
Mar 31, 2017
$0
May 1, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$659.90M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$603.31M
Jul 22, 2025
Q1
2025
Mar 31, 2025
$558.57M
Apr 22, 2025
Q3
2025
Sep 30, 2024
$533.32M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$528.10M
Jul 22, 2025
Q1
2025
Mar 31, 2024
$511.04M
Apr 22, 2025
Q3
2024
Sep 30, 2023
$492.50M
Oct 22, 2024
Q2
2024
Jun 30, 2023
$460.87M
Jul 23, 2024
Q1
2024
Mar 31, 2023
$434.07M
Apr 23, 2024
Q3
2023
Sep 30, 2022
$383.74M
Oct 24, 2023
Q2
2023
Jun 30, 2022
$351.21M
Jul 25, 2023
Q1
2023
Mar 31, 2022
$330.95M
Apr 25, 2023
Q3
2022
Sep 30, 2021
$295.57M
Oct 25, 2022
Q2
2022
Jun 30, 2021
$278.29M
Jul 26, 2022
Q1
2022
Mar 31, 2021
$259.97M
Apr 26, 2022
Q3
2021
Sep 30, 2020
$230.37M
Oct 26, 2021
Q2
2021
Jun 30, 2020
$205.00M
Jul 27, 2021
Q1
2021
Mar 31, 2020
$230.88M
Apr 27, 2021
Q3
2020
Sep 30, 2019
$216.24M
Oct 27, 2020
Q2
2020
Jun 30, 2019
$214.10M
Jul 28, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$163.08M
May 1, 2018
Q3
2017
Sep 30, 2017
$110.64M
Oct 31, 2017
Q2
2017
Jun 30, 2017
$106.22M
Aug 1, 2017
Q1
2018
Mar 31, 2017
$106.61M
May 1, 2018
Q3
2017
Sep 30, 2016
$107.80M
Oct 31, 2017
Q2
2017
Jun 30, 2016
$105.95M
Aug 1, 2017
Q1
2017
Mar 31, 2016
$99.59M
May 2, 2017
Q3
2016
Sep 30, 2015
$92.13M
Nov 3, 2016
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$111.14M
Oct 23, 2025
Q3
2025
Jun 30, 2025
$90.26M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$90.26M
Jul 22, 2025
Q2
2025
Mar 31, 2025
$114.60M
Jul 22, 2025
Q1
2025
Mar 31, 2025
$114.60M
Apr 22, 2025
Q3
2025
Mar 31, 2025
$114.60M
Oct 23, 2025
Q3
2025
Sep 30, 2024
$96.43M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$88.35M
Jul 22, 2025
Q3
2025
Jun 30, 2024
$88.35M
Oct 23, 2025
Q3
2025
Mar 31, 2024
$102.59M
Oct 23, 2025
Q2
2025
Mar 31, 2024
$102.59M
Jul 22, 2025
Q1
2025
Mar 31, 2024
$102.59M
Apr 22, 2025
Q3
2024
Sep 30, 2023
$70.55M
Oct 22, 2024
Q3
2024
Jun 30, 2023
$61.07M
Oct 22, 2024
Q2
2024
Jun 30, 2023
$61.07M
Jul 23, 2024
Q2
2024
Mar 31, 2023
$72.89M
Jul 23, 2024
Q3
2024
Mar 31, 2023
$72.89M
Oct 22, 2024
Q1
2024
Mar 31, 2023
$72.89M
Apr 23, 2024
Q3
2023
Sep 30, 2022
$66.03M
Oct 24, 2023
Q3
2023
Jun 30, 2022
$49.36M
Oct 24, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$141.81M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$126.34M
Jul 22, 2025
Q1
2025
Mar 31, 2025
$113.52M
Apr 22, 2025
Q3
2025
Sep 30, 2024
$112.27M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$105.15M
Jul 22, 2025
Q1
2025
Mar 31, 2024
$104.07M
Apr 22, 2025
Q3
2024
Sep 30, 2023
$84.91M
Oct 22, 2024
Q2
2024
Jun 30, 2023
$78.39M
Jul 23, 2024
Q1
2024
Mar 31, 2023
$86.20M
Apr 23, 2024
Q3
2023
Sep 30, 2022
$77.83M
Oct 24, 2023
Q2
2023
Jun 30, 2022
$60.24M
Jul 25, 2023
Q1
2023
Mar 31, 2022
$64.20M
Apr 25, 2023
Q3
2022
Sep 30, 2021
$53.71M
Oct 25, 2022
Q2
2022
Jun 30, 2021
$42.45M
Jul 26, 2022
Q1
2022
Mar 31, 2021
$47.60M
Apr 26, 2022
Q3
2021
Sep 30, 2020
$46.42M
Oct 26, 2021
Q2
2021
Jun 30, 2020
$30.13M
Jul 27, 2021
Q1
2021
Mar 31, 2020
$35.50M
Apr 27, 2021
Q3
2020
Sep 30, 2019
$29.99M
Oct 27, 2020
Q2
2020
Jun 30, 2019
$35.26M
Jul 28, 2020